Srivani Ravoori, PhD, discusses some of the AACR Annual Meeting 2015 presentations that evaluated the promise of combining immunotherapies for advanced melanoma.
American Association for Cancer Research Recognizes 2015 Research Grantees at Annual Meeting
AACR, ABC News’ Dr. Richard Besser Use Twitter’s Periscope to Live Stream “Breakthroughs in Cancer Research” From 2015 Annual Meeting
Olaparib–Carboplatin Combination Showed Early Signs of Clinical Activity Against Ovarian and Triple-negative Breast Cancers
New PARP Inhibitor Combo Shows Early Promise for Cancer Patients With and Without BRCA Mutations
AACR Annual Meeting 2015, April 18-22, 2015
Advances in Brain Cancer Research, May 27-30, 2015
Metabolism and Cancer, June 7-10, 2015
Methods in Cancer Biostatistics Workshop: Clinical Trial Designs for Targeted Agents, June 7-13, 2015
Karen Honey, PhD, discusses new data released at the AACR Annual Meeting 2015 on the PD-1 inhibitor pembrolizumab (Keytruda) that have the potential to lead to further changes in clinical practice.